News Release

First delivery of “CellQualia™ Intelligent Cell Processing System”, the world-first smart automated cell-culture system


To the project promoted by Fujita Academy and Keio University
to Establish Infrastructure for Social Implementation of Cellular Medicine
for Regenerative and Gene Therapy in East Japan

TOKYO, May 29, 2024 - SINFONIA TECHNOLOGY CO., LTD. (TSE: 6507) has delivered 2 units of an automated cell-culture system CellQualia™ Intelligent Cell Processing (ICP)System to Keio University in March and finished Performance Qualification in April in this year. This device will play a role in the stable production and supply of high-quality cell medicines for the realization of regenerative medicine, which is highly expected to be a next-generation medical treatment.

Sinfonia have been developing next-generation smart automated cell culture systems in collaboration with Dr. Shin Kawamata, an international leader in the quality control of cell manufacturing (CEO, Cyto-Facto Inc., and Specially Appointed Professor, Kobe University). As an outcome of the collaboration, Sinfonia have succeeded in incorporating the concept of Quality by Design (QbD) into an automated cell culture system for the first time in the world. The system consistently monitors the entire culture process and manufactures the product while ensuring the quality of the process. This has enabled us to manufacture cellular medicine automatically while monitoring the process.

The development of this device has been completed in October 2021, and performance tests continued at both Sinfonia Kobe Solutions Laboratory and the UK Stem Cell Bank. Comparable data to Sinfonia and good performance at UK Stem Cell Bank demonstrate that the device is convenient and reliable. The results of these experiments were presented at Annual Meeting of the International Society for Cell and Gene Therapy held in Paris in May of 2023.


The system was installed in a new cell-based drug production facility on Research Gate Building4 floor of the Tonomachi Town Campus of Keio University. Keio University and Fujita Gakuen have concluded a partnership agreement for the social implementation of advanced medical technology and the promotion of industry-academia-public collaboration activities, mainly in the Haneda and Tonomachi areas. We expect that our equipment will make a significant contribution to the stable production and supply of high-quality cell medicines for regenerative medicine.


Sinfonia was established in 1917, with electromagnetic control technology as its core, providing various products including clean transport devices (semiconductors) and electrical components for space rockets and aircraft. They are based on our own technologies across four sectors: Clean Transport Systems, Power Electronics Equipment, Motion Equipment, and Engineering and Services. Today, Sinfonia applies these technologies cultivated in various fields and continues to contribute to further social progress by developing products used in sectors including Regenerative Medicine, Logistics, and Agriculture.  

The company's revenues for the fiscal year 2022 (ended March 31, 2023) totaled 108.8 billion yen, with 3,680 consolidated employees. 



For further information, please contact: HERE